Vascular regenerative cells in cardiometabolic disease
Ehab Bakbak(The University of Queensland), David A. Hess(Western University), Aishwarya Krishnaraj(St. Michael's Hospital), Brady Park(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital)
Cited by 7
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
New Markers of Inflammation and Endothelial Cell Activation
|Circulation|2003|733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Endothelial cell control of thrombosis
|BMC Cardiovascular Disorders|2015|678